Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

Constitutive CD40 signaling in B cells selectively activates the noncanonical NF-kappaB pathway and promotes lymphomagenesis.

Hömig-Hölzel C, Hojer C, Rastelli J, Casola S, Strobl LJ, Müller W, Quintanilla-Martinez L, Gewies A, Ruland J, Rajewsky K, Zimber-Strobl U.

J Exp Med. 2008 Jun 9;205(6):1317-29. doi: 10.1084/jem.20080238. Epub 2008 May 19.

2.
3.

Differential B-lymphocyte regulation by CD40 and its viral mimic, latent membrane protein 1.

Graham JP, Arcipowski KM, Bishop GA.

Immunol Rev. 2010 Sep;237(1):226-48. doi: 10.1111/j.1600-065X.2010.00932.x. Review.

PMID:
20727039
4.

CD40-CD40 ligand.

van Kooten C, Banchereau J.

J Leukoc Biol. 2000 Jan;67(1):2-17. Review.

PMID:
10647992
5.

The CD40-CD154 interaction in B cell-T cell liaisons.

Bishop GA, Hostager BS.

Cytokine Growth Factor Rev. 2003 Jun-Aug;14(3-4):297-309. Review.

PMID:
12787567
6.
7.

Outside inside signalling in CD40-mediated B cell activation.

D'Orlando O, Gri G, Cattaruzzi G, Merluzzi S, Betto E, Gattei V, Pucillo C.

J Biol Regul Homeost Agents. 2007;21(3-4):49-62. Review.

PMID:
18261257
8.

Dissecting the role of lymphotoxin in lymphoid organs by conditional targeting.

Tumanov AV, Grivennikov SI, Shakhov AN, Rybtsov SA, Koroleva EP, Takeda J, Nedospasov SA, Kuprash DV.

Immunol Rev. 2003 Oct;195:106-16. Review.

PMID:
12969314
9.

CD40: a growing cytoplasmic tale.

Harnett MM.

Sci STKE. 2004 Jun 9;2004(237):pe25. Review.

PMID:
15199223
10.

CD40 signaling and autoimmunity.

Cheng G, Schoenberger SP.

Curr Dir Autoimmun. 2002;5:51-61. Review. No abstract available.

PMID:
11826760
11.
12.

CD22: a multifunctional receptor that regulates B lymphocyte survival and signal transduction.

Tedder TF, Poe JC, Haas KM.

Adv Immunol. 2005;88:1-50. Review.

PMID:
16227086
13.

Genetic dissection of antigen receptor induced-NF-kappaB activation.

Li ZW, Rickert RC, Karin M.

Mol Immunol. 2004 Jul;41(6-7):701-14. Review.

PMID:
15220005
14.

Effects of CD40 stimulation in the prevention of human EBV-lymphomagenesis.

Funakoshi S, Taub DD, Asai O, Hirano A, Ruscetti FW, Longo DL, Murphy WJ.

Leuk Lymphoma. 1997 Jan;24(3-4):187-99. Review.

PMID:
9156649
15.

The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis.

Brown KD, Claudio E, Siebenlist U.

Arthritis Res Ther. 2008;10(4):212. doi: 10.1186/ar2457. Epub 2008 Aug 21. Review.

16.

Exosome release by primary B cells.

McLellan AD.

Crit Rev Immunol. 2009;29(3):203-17. Review.

PMID:
19538135
17.

Requirement for reverse immune surveillance for the growth of germinal center-derived murine lymphomas.

Ponzio NM, Thorbecke GJ.

Semin Cancer Biol. 2000 Oct;10(5):331-40. Review.

PMID:
11100880
18.

Tumor-specific adoptive T-cell therapy for CD40+ B-cell malignancies.

Schultze JL, Gribben JG, Nadler LM.

Curr Opin Oncol. 1998 Nov;10(6):542-7. Review.

PMID:
9818233
19.

A molecular basis for T-dependent B cell activation.

Lane P.

Behring Inst Mitt. 1995 Jun;(96):7-12. Review.

PMID:
7575354
20.

CD40 and its viral mimic, LMP1: similar means to different ends.

Lam N, Sugden B.

Cell Signal. 2003 Jan;15(1):9-16. Review.

PMID:
12401515

Supplemental Content

Support Center